Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026)
Capricor Therapeutics' (CAPR) quarterly Other Non Operating Income came in at -$72998.0 in Q1 2026, up 47.17% year-on-year from -$49599.5 in Q1 2025, and up 47.17% quarter-over-quarter from -$138188.0 in Q1 2025.
Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$72998.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 47.17% year-over-year to -$72998.0 in Q1 2026; TTM through Mar 2026 was $118711.0, a 33.14% increase from a year earlier, with the FY2025 full-year figure at $399695.0, down 34.74% from the prior year.
- Other Non Operating Income improved to -$72998.0 in Q1 2026 per CAPR's latest filing, from -$138188.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$72998.0 in Q1 2026 and bottomed at -$138188.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Capricor Therapeutics | 1.12 Bn | 1.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72,998.00 |
| Mar 31, 2025 | -138,188.00 |
| Jun 30, 2021 | 318,160.00 |
| Sep 30, 2013 | 11,737.00 |
| Jun 30, 2013 | -102,545.00 |
| Mar 31, 2013 | -144,705.00 |
| Dec 31, 2012 | 117,466.00 |
| Sep 30, 2012 | 9,771.00 |
| Jun 30, 2012 | 420,890.00 |
| Mar 31, 2012 | -2,250.00 |
| Dec 31, 2011 | -513.00 |
| Sep 30, 2011 | 10,411.00 |
| Jun 30, 2011 | -1,341.00 |
| Mar 31, 2011 | -168.00 |
| Dec 31, 2010 | 244,478.00 |
| Sep 30, 2010 | -2,711.00 |
| Jun 30, 2010 | -40.00 |